Title: Antonin Morillon: Innovator in Prostate Cancer Diagnosis
Introduction
Antonin Morillon is a notable inventor based in Paris, France. He has made significant contributions to the field of cancer diagnostics, particularly focusing on prostate cancer. Although he currently holds no granted patents, his work in research institutions has been impactful.
Latest Patent Applications
Antonin Morillon has filed several patent applications aimed at improving the diagnosis of prostate cancer. One of his latest applications is titled "Use of Long Non-Coding RNA for the Diagnosis of Prostate Cancer." This invention provides long noncoding RNAs (lncRNAs) that allow for a more accurate diagnosis of prostate cancer compared to existing non-invasive diagnostic tools. It relates to the use of at least one of these lncRNAs or a combination thereof as a diagnostic marker for prostate cancer. Additionally, it includes an in vitro method for diagnosing prostate cancer in a subject, as well as a kit for performing this method.
Another significant application is "Use of Antisense Long Non-Coding RNAs for the Diagnosis of Prostate Cancer." This invention introduces three new antisense long non-coding RNAs (lncRNAs) that enhance the accuracy of prostate cancer diagnosis. Similar to the previous application, it involves the use of these antisense lncRNAs as diagnostic markers and includes an in vitro method and a kit for diagnosis.
Conclusion
Antonin Morillon's innovative work in the field of prostate cancer diagnostics showcases his commitment to advancing medical research. His latest patent applications reflect a promising direction in non-invasive diagnostic tools for cancer.